Seminars in Cancer Biology (SCB) is a scholarly journal dedicated to publishing research in the field of Biochemistry Genetics and Molecular Biology. Elsevier is the publisher of this esteemed journal. The P-ISSN assigned to Seminars in Cancer Biology is 1044-579X and its abbreviated form is Semin Cancer Biol.
Seminars in Cancer Biology is a review journal dedicated to keeping scientists informed of developments in the field of molecular oncology on a topic by topic basis. Each issue is thematic in approach, devoted to an important topic of interest to cancer biologists, from the underlying genetic and molecular causes of cellular transformation and cancer to the molecular basis of potential therapies. Every issue is edited by a guest editor or editors, an internationally acknowledged expert(s) in the field, and contains approximately eight to twelve authoritative invited reviews on different aspects of the subject area. The aim of each issue is to provide a coordinated, readable, and lively review of a selected area, published rapidly to ensure currency.
Topics that will be covered in the next issues are as follows:
• Role of glycation in different types of cancer
• Immuno-Oncological Biomarkers
• Epigenetics: solid tumors and haematological malignancies
• Current Vision on target enzymes for cancer therapy
• Translational Cancer Genomics
• FOXO family in cancer
• Emerging trends in biomarker discovery: ease of prognosis and prediction in cancer
• Some chinks in Ras armor: novel cancer therapeutics on the horizon
• Conference - Cancer Stem Cells: impact on treatment
Journal title | Seminars in Cancer Biology (SCB) |
Abbreviation | Semin Cancer Biol |
Print ISSN | 1044-579X |
Online ISSN | 1096-3650 |
Publisher Name | Elsevier |
Editor-in-chief | Theresa Vincent, PhD |
Subject Category | Biochemistry Genetics and Molecular Biology |
Abbreviation : ISO Journal abbreviation refers to the shortened form or acronym used to represent the full title of a scholarly journal. The ISO4 Abbreviation of Seminars in Cancer Biology Journal is Semin Cancer Biol.
The Ranking of the Journal in 2024 is 575. Ranking systems aim to provide an indication of a journal's quality, influence, and prestige within a specific field or discipline.
The Journal's Impact Factor in 2024 is 14.5. it is all calculated by Clarivate, which means how many times a particular citation has been published in the past two years.
The Journal SCImago in 2024 is 2.556. It is measured by the number of citations which are made by the particular journals, and the journal from where the citations arrived from.
The Journal's H-Index in 2024 is 169. The H-index is calculated on how many times a particular author is cited and the number of published papers that a particular author has.
The Journal's Quartile is Q1. A quartile has three points, which are the upper quartile, median, and lower quartile. The main motive of the quartile is to calculate the interquartile range, that resembles the changes across the median.
The Journal is indexed in (Indexing details)
PubMed | Scopus | Web of Science | UGC | Embase | DOAJ |
---|---|---|---|---|---|
✅ | ✅ | ✅ | ✅ | ✅ | ❌ |
Indexing services aim to make it easier for researchers, scholars, and readers to discover and access articles from various journals within a specific field or discipline.
Abbreviation | Semin Cancer Biol |
Access type | Hybrid |
Impact Factor | 14.5 |
SJR | 2.556 |
SNIP | 3.115 |
Ranking | 575 |
CiteScore | 20.0 |
H-Index | 169 |
Processing/Submission Fee : Article submission/Processing fees (APC), also known as manuscript Publication fees or processing fees (APC), are charged by journals to authors for submitting/publishing their research papers/article.
The APC/Submission (Publication) Fee of the Journal is $5150
Call for paper : The Journal invites original research contributions for consideration of publication in Seminars in Cancer Biology journal.
Journal seeking submissions in the broad areas of Biochemistry Genetics and Molecular Biology that align with journal's focus on Biochemistry Genetics and Molecular Biology.
for details about call for paper please visit to the official website of the journal to check the details about call for papers.
Publishing in Seminars in Cancer Biology involves the following steps:
Yes, the journal is indexed in PubMed.
Yes, the journal is indexed in Scopus.
Yes, the journal is indexed in UGC.
No, the journal is not indexed in Index copernicus.
No, journal is not a predatory journal.
The Impact Factor of the Journal is 14.5.
The Ranking of the Journal is 575.
Yes the journal is a peer-reviewed journal.
Yes the journal is a peer-reviewed journal and good to publish your paper.
Seminars in Cancer Biology (SCB) is a scholarly journal dedicated to publishing research in the field of Biochemistry Genetics and Molecular Biology. Elsevier is the publisher of this esteemed journal.
Yes, Seminars in Cancer Biology is a open access (Hybrid) journal.